Close

Working together towards a world free from MND

Reading Time: 4 minutes During MND Awareness Month we are highlighting some of the research the MND Association funds in our ‘Project a Day’ series. Today, on global ALS/MND awareness day, we wanted to give you a look at the research into motor neurone disease taking place elsewhere. Thousands of researchers across the globe are working towards a world…

Stem cell trials in the news

Reading Time: 4 minutes The recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem cell amyotrophic lateral sclerosis (ALS) clinical trial in Israel have raised the profile of stem cells as a possible treatment for motor neurone disease. Stem cells are unspecialised cells in…

Changing the way we think about the causes of MND

Reading Time: 3 minutes Adult onset condition, those with genetic mutations associated with the disease don’t get it until they’re adults, starts in one place and then it spreads, once it occurs the progression is usually relentless….   what condition am I describing? Professor Neil Pearce’s point in his talk at the opening session of the International Symposium on…

International Symposium on ALS/MND: Destination Orlando

Reading Time: 4 minutes The August Bank holiday weekend is always greeted with a sigh of relief from the Research Development Team as it signals the sending off of the International Symposium on ALS/MND abstract book to the publishers. The book includes teasers/previews – called abstracts – of all the talks and posters that will be presented at this…

Formaldehyde exposure and increased risk of developing MND

Reading Time: 3 minutes A new study published yesterday in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) highlights the link between increased exposure to formaldehyde and an increased risk of developing MND. The study in the USA was conducted by Andrea Roberts and colleagues at the Department of Social and Behavioural Sciences at Harvard. They investigated whether a person’s exposure…

Understanding more about GM604

Reading Time: 3 minutes The MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company Genervon. The Association funds a wide range of research that leads to new understanding and treatments, which may one day, bring us closer to a cure for MND. We are hopeful…